Stay updated on REFINE: Natalizumab Regimens in Relapsing MS Clinical Trial

Sign up to get notified when there's something new on the REFINE: Natalizumab Regimens in Relapsing MS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the REFINE: Natalizumab Regimens in Relapsing MS Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Update includes a critical operating status notice and a new software version (v3.2.0), indicating updated deployment with potential service impact; previous version reference (v3.1.0) was removed.
    Difference
    4%
    Check dated 2025-10-05T10:19:45.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    - Added Revision: v3.1.0. - Removed several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and an older Revision: v3.0.2. The page now updates its version and omits multiple drug-safety-related topics.
    Difference
    0.6%
    Check dated 2025-09-28T03:19:59.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Update: Revision changed from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.
    Difference
    0.2%
    Check dated 2025-09-13T17:40:19.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-06T15:21:27.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a comprehensive list of locations across several countries and a focus on drug safety topics, while also removing outdated location details and specific drug information.
    Difference
    6%
    Check dated 2025-08-30T11:52:58.000Z thumbnail image
  9. Check
    76 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T04:39:51.000Z thumbnail image

Stay in the know with updates to REFINE: Natalizumab Regimens in Relapsing MS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the REFINE: Natalizumab Regimens in Relapsing MS Clinical Trial page.